Disease Info Card

Nephrosclerosis

Information about Nephrosclerosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Nephrosclerosis

Most recent studies have shown that Nephrosclerosis shares some biological mechanisms with arteriosclerosis, diabetes-mellitus, diabetic-nephropathy, essential-hypertension, fibrosis, glomerulonephritis, glomerulosclerosis-(disorder), hypertensive-disease, infection-of-kidney, kidney-diseases, kidney-failure, kidney-failure-chronic, malignant-hypertension, malignant-paraganglionic-neoplasm, nephritis, nephrotic-syndrome, proteinuria-of-undiagnosed-cause, renal-hypertension, renal-insufficiency, sclerosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Nephrosclerosis, and have been seen in publications frequently: Aging, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Diuresis, Excretion, Glomerular Filtration, Localization, Natriuresis, Pathogenesis, Platelet Aggregation, Protein Secretion, Regeneration, Secretion, Senescence, Transport, Vasoconstriction, Vasodilation

Quite a number of genes have been found to play important roles in Nephrosclerosis, such as ACE, ACTN4, AGT, ALB, ANG, C3, CRP, FN1, HTT, INS, LYZ, PTH, RANGAP1, RAPGEF5, REN, SERPINE1, SLC17A5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.